MHRA’s regulatory renaissance: Why the UK is now a strategic hub for early clinical trials

Why has the UK emerged as a strategic hub for early-phase clinical trials?

Fortrea Thought Leadership: Unraveling the Link Between Obesity, Metabolic Inflammation, and Cancer

Fortrea’s latest review uncovers the molecular links between metabolic inflammation, obesity and cancer—and highlights new opportunities for prevention and precision oncology.

Hope in a Dose: A Cell and Gene Therapy (CGT) Podcast

Safety Blog: AI in Medical Writing: Disruption or Evolution?

Leeds

Discover Fortrea’s Leeds Clinical Research Unit — delivering early-phase clinical trial excellence with advanced facilities, expert teams, and UK’s strong research ecosystem.

Reducing white space in early-stage drug development: Strategies for streamlined success

Enabling success in global clinical trials: Fortrea’s strategic solutions for biotech

Bridging the Gaps: How Integration Accelerates Biotech Development

Accelerate biotech development with Fortrea’s integrated solutions—closing gaps between strategy and execution.

Safety Blog - Crafting Clarity from Complexity: Transforming clinical trial data into a clear, compelling narrative that informs, influences, and inspires.

Digital endpoints in neuroscience: From breakthrough potential to breakthrough results